Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "standard"

1852 News Found

Gen Z split on AI as global study reveals rising tech optimism
Technology | April 30, 2026

Gen Z split on AI as global study reveals rising tech optimism

Health innovations are viewed more positively than food and agricultural technologies


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services


Cardioline acquires Cardios to expand global telecardiology footprint
Medical Device | April 30, 2026

Cardioline acquires Cardios to expand global telecardiology footprint

Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions


Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
Biotech | April 29, 2026

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology

The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use


Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis
Healthcare | April 29, 2026

Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis

The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder


The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
interviews | April 28, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints


EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control
Medical Device | April 28, 2026

EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control

The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs


AKUMS launches Aztreonam-Avibactam injection to combat multidrug-resistant infections
News | April 28, 2026

AKUMS launches Aztreonam-Avibactam injection to combat multidrug-resistant infections

The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand


AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
Drug Approval | April 28, 2026

AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease

The submission is backed by positive results from the Phase 3 AFFIRM study


Essilor Stellest lens positioned as key breakthrough in myopia control in India
News | April 28, 2026

Essilor Stellest lens positioned as key breakthrough in myopia control in India

The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025